All manuscripts
Publications CAR T Cells

Chimeric antigen receptor structure and manufacturing of clinical grade CAR engineered cells using different bioreactors

Published Journal Hematology/Oncology and Stem Cell Therapy

Share
No image preview

Overview

This review discusses CAR structure and automated manufacturing platforms. It highlights the G-Rex® (M series) and GatheRex pump as a practical, cost-effective, and scalable static culture option for CAR-T expansion.

What this paper found

This review surveys automated and semi-automated closed platforms for manufacturing clinical-grade CAR-engineered cells and identifies automation with closed systems as a main route to lowering cost of goods. It first outlines the four regions of a CAR: antigen-recognition, hinge or spacer, transmembrane and intracellular signalling domains. Platforms compared include the CliniMACS Prodigy, Cocoon, Quantum, Xuri W25, G-Rex® M series, CTS Rotea and stirred-tank bioreactors. The Quantum hollow-fiber bioreactor offers 2.1 m² of culture surface, equal to 120 T175 flasks; the Xuri W25 handles 300 mL to 25 L; and G-Rex® vessels scale from 2 to 500 cm², reaching CAR-T harvest densities of 20–30 × 10^6 cells per cm² in 9–14-day cultures. Several platforms still need manual steps or separate instruments for selection or electroporation.

Note: Narrative review with no new experimental data; the authors note that some platforms, such as the ekko system, have limited published reports on their use for CAR-engineered cell production.

Improving manufacturing efficiency through automation is one of the big challenges that will need to be addressed to reduce high cost of goods (CoGs). — Farhatullah Syed, Riad El Fakih, Ali Debsan Alahmari, Ahmed Syed Osman Ali, Mahmoud Aljurf, Hematology/Oncology and Stem Cell Therapy

Study details

Authors
Farhatullah Syed, Riad El Fakih, Ali Debsan Alahmari, Ahmed Syed Osman Ali, Mahmoud Aljurf
Institution
Stem Cell & Tissue Re-engineering Program (Dpt)-R., King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia · Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
Journal
Hematology/Oncology and Stem Cell Therapy
Year
2022
PMID / PMC
PMID: 36395497
Cell type(s)
CAR T Cells
Application area
Hematologic malignancy

Explore related

Full citation

Syed F, El Fakih R, Alahmari AD, Osman Ali AS, Aljurf M. Chimeric Antigen Receptor Structure and Manufacturing of Clinical Grade CAR Engineered Cells using Different Bioreactors. Hematol Oncol Stem Cell Ther. 2022;15(3):137-152.

Building a similar workflow?

Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.

Start a conversation →